Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Jonathan Schoenfeld, MD, MPhil, MPH

Advertisement

Articles by Jonathan Schoenfeld, MD, MPhil, MPH

Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation

ByJonathan Schoenfeld, MD, MPhil, MPH
October 28th 2016

Jonathan Schoenfeld discusses the patient profile that would benefit best from a combination of radiation and immunotherapy.

Advertisement

Latest Updated Articles

  • Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation
    Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation

    October 28th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

National Cancer Institute Explores Ivermectin as a Potential Cancer Therapy

2

FDA Approves Sacituzumab Govitecan-hziy for First-Line Triple-Negative Breast Cancer

3

FDA Approves Palbociclib for HR+/HER2+ Metastatic Breast Cancer Maintenance

4

GLP-1 Therapies May Reduce Cardiovascular Risks for Breast Cancer Survivors

5

'Somebody That Feels Like a Friend': Teddi Mellencamp Honors Oncology Nurses

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us